Domainex (AgeTech UK) Biomed
Drug discovery services. Domainex is Europe's fastest growing drug discovery CRO. It serves pharmaceutical, biotechnology, academic and patient foundations globally. Domainex’s drug discovery service business was established in 2001 and since that time has continued to expand to serve a wider range of international clients including UCB, FORMA Therapeutics, St George’s University, and The Institute of Cancer Research.
Technology:
AgeTech Companies
Funding Status:
N/A
Number Of Exists:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Employee Number:
N/A
Headquarters:
United Kingdom
Founded Date:
N/A
Industry:
UK AgeTech 2020